Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060388HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TVIS10062365HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TVIS10062366HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TVIS10062367HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TVIS10062368HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TVIS10062369HBVENSG00000197249.14protein_codingSERPINA1NoNo5265E9KL23
P01009
TCGA Plot Options
Drug Information
GeneSERPINA1
DrugBank IDDB01593
Drug NameZinc
Target IDBE0000952
UniProt IDP01009
Regulation Type
PubMed IDs23896426
CitationsWang F, Chmil C, Pierce F, Ganapathy K, Gump BB, MacKenzie JA, Metchref Y, Bendinskas K: Immobilized metal affinity chromatography and human serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:26-33. doi: 10.1016/j.jchromb.2013.06.032. Epub 2013 Jul 5.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279